In Epstein-Barr virus infection, cross-reactive memory CD8+ T cells have demonstrated broad peptide reactivity—even across distinct HLA alleles—highlighting degenerate peptide recognition as a mechanism for sustained antiviral control [32]. This evidence concerns the gene CD8A and Epstein-Barr virus infection.